The first ESO Umberto Veronesi Memorial Award
Professor Umberto Veronesi died peacefully on 9 November 2016 at age 91 surrounded by his wife and 7 children and many grandchildren, fading away with his unique and unforgettable smile at home in Milan.
He was an authentic Master of Science in that he used a pedagogic method based on the active participation of his collaborators towards the search for their own professional direction and scientific interest. His greatest gift was his skill to attain the best from his collaborators, promoting their career based on merit. He instilled in many people his real passion for research. He was able to build warm and reassuring relationships with his collaborators thanks to his elegant and charming way so that each of them was encouraged to give their best.
The scientist Veronesi was a champion in breast cancer surgery: he was the first to demonstrate that conservative surgery with quadrantectomy was equivalent to radical mastectomy. Subsequently, he first introduced the use of sentinel lymph node biopsy to avoid axillary dissection in clinically negative lymph node breast cancer. These procedures have changed the practice of breast cancer surgery worldwide and saved millions of women from the trauma of a mutilating surgery. Likewise, in the field of prevention Veronesi pioneered the concept of chemoprevention by assessing the retinoid fenretinide and later tamoxifen to prevent breast cancer.
Veronesi as a physician operated on more than 30.000 women in his career. He was in the surgical theatre nearly every day and had an intense clinical activity up until a couple of years ago. He was a reassuring doctor with human behavior and most women were enthusiastic of him. His surgical skill was outstanding and remains a reference point in terms of cosmetic results as well.
Veronesi the manager, after having contributed to founding the National Cancer Institute in Milan, he established the European Institute of Oncology: two internationally recognized centres of excellence for research in oncology. He was a great talent recruiter and he firmly believed in the equation “good research, better care”.
He was founder and president of most of the European scientific societies (surgical oncology, mastology, the federation of cancer societies FECS, now ECCO) as well as president of EORTC, UICC and many other organisations.
He founded the European School of Oncology in 1982, and dedicated a lot of time and energy to education and teaching. In 2003 he established the Umberto Veronesi Foundation, a charity aimed to fund academic research which today is also an important vehicle for scientific knowledge and through Science for Peace also a promotion of social solidarity for underserved populations.
Umberto Veronesi was a citizen of the world, but always proud of being Italian, serving his country as Minister of Health and as Senator. In 2000 he promoted the Italian law against smoking in public places, an initiative which aroused admiration and emulation in other European countries and will help to save many lives from passive smoking damages.
Veronesi, the man of culture promoted great civil battles such as the biological testament and the right for a good death characterized by ideas and positions based on logical principles in the name of scientific thought. He was secular, but he had a deep knowledge of religions and their history. A nonconformist who believed that prevention is the way forward in the current era of medicine dominated by economic interests and questionable cost effective treatments.
His typical statement at the end of internal meetings was "You should think bigger and conceive studies which represent a breakthrough for medicine." A lesson not easy to follow up.
To honor the memory of its founder, the European School of Oncology has established the ESO Umberto Veronesi Memorial Award that aims at recognizing a physician’s leading role in advancing science and care of breast cancer patients.
The first ESO Umberto Veronesi Memorial Award is given to Professor Giuseppe Curigliano on the occasion of the 15th St. Gallen International Breast Cancer Conference. Professor Giuseppe Curigliano is director of the Division of Experimental Therapeutics at the European Institute of Oncology, Milan, Italy.
Professor Giuseppe Curigliano receiving his Award from Dr Alberto Costa at the 15th St Gallen International Breast Cancer Conference on 15th March 2017